UTMD
Utah Medical Products Inc
74.20$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.5% | 39.8% | 39.7% | 36.3% | 37.4% | 37.2% | 39.4% | 37.0% | 38.4% | 40.2% | 41.0% | 48.4% | |
| 60.5% | 60.2% | 60.3% | 63.7% | 62.6% | 62.8% | 60.6% | 63.0% | 61.6% | 59.8% | 59.0% | 51.6% | |
| 1.1% | 1.3% | 1.2% | 1.1% | 1.1% | 1.0% | 1.2% | 1.1% | 0.9% | 1.1% | 2.0% | 1.7% | |
| 14.8% | 14.6% | 13.6% | 13.0% | 13.0% | 20.5% | 23.2% | 20.6% | 19.9% | 21.9% | 9.0% | 25.8% | |
| 21.3% | 21.3% | 19.1% | 17.8% | 18.1% | 25.2% | 28.1% | 24.5% | 23.7% | 26.4% | 25.8% | 22.0% | |
| 39.3% | 39.0% | 41.2% | 45.9% | 44.5% | 37.6% | 32.5% | 38.5% | 37.9% | 33.4% | 33.2% | 29.6% | |
| 0.7% | 0.2% | 0.0% | 0.0% | 0.0% | 15.2% | 17.4% | 8.5% | 1.7% | – | – | – | |
| 38.3% | 38.7% | 41.8% | 46.1% | 46.3% | 38.1% | 32.8% | 38.9% | 39.5% | 40.0% | 41.1% | 36.6% | |
| 10.7% | 9.2% | 10.9% | 25.5% | 2.2% | 6.7% | 7.2% | 8.7% | 8.0% | 6.9% | 7.2% | 7.3% | |
| 27.6% | 29.5% | 30.9% | 20.5% | 44.2% | 31.4% | 25.6% | 30.1% | 31.5% | 33.1% | 33.9% | 29.3% | |
| 47.6% | 46.9% | 48.4% | 52.6% | 51.6% | 52.3% | 49.6% | 53.7% | 53.1% | 49.3% | 47.9% | 44.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.